Literature DB >> 21979811

Multitargeting by curcumin as revealed by molecular interaction studies.

Subash C Gupta1, Sahdeo Prasad, Ji Hye Kim, Sridevi Patchva, Lauren J Webb, Indira K Priyadarsini, Bharat B Aggarwal.   

Abstract

Curcumin (diferuloylmethane), the active ingredient in turmeric (Curcuma longa), is a highly pleiotropic molecule with anti-inflammatory, anti-oxidant, chemopreventive, chemosensitization, and radiosensitization activities. The pleiotropic activities attributed to curcumin come from its complex molecular structure and chemistry, as well as its ability to influence multiple signaling molecules. Curcumin has been shown to bind by multiple forces directly to numerous signaling molecules, such as inflammatory molecules, cell survival proteins, protein kinases, protein reductases, histone acetyltransferase, histone deacetylase, glyoxalase I, xanthine oxidase, proteasome, HIV1 integrase, HIV1 protease, sarco (endo) plasmic reticulum Ca(2+) ATPase, DNA methyltransferases 1, FtsZ protofilaments, carrier proteins, and metal ions. Curcumin can also bind directly to DNA and RNA. Owing to its β-diketone moiety, curcumin undergoes keto-enol tautomerism that has been reported as a favorable state for direct binding. The functional groups on curcumin found suitable for interaction with other macromolecules include the α, β-unsaturated β-diketone moiety, carbonyl and enolic groups of the β-diketone moiety, methoxy and phenolic hydroxyl groups, and the phenyl rings. Various biophysical tools have been used to monitor direct interaction of curcumin with other proteins, including absorption, fluorescence, Fourier transform infrared (FTIR) and circular dichroism (CD) spectroscopy, surface plasmon resonance, competitive ligand binding, Forster type fluorescence resonance energy transfer (FRET), radiolabeling, site-directed mutagenesis, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), immunoprecipitation, phage display biopanning, electron microscopy, 1-anilino-8-naphthalene-sulfonate (ANS) displacement, and co-localization. Molecular docking, the most commonly employed computational tool for calculating binding affinities and predicting binding sites, has also been used to further characterize curcumin's binding sites. Furthermore, the ability of curcumin to bind directly to carrier proteins improves its solubility and bioavailability. In this review, we focus on how curcumin directly targets signaling molecules, as well as the different forces that bind the curcumin-protein complex and how this interaction affects the biological properties of proteins. We will also discuss various analogues of curcumin designed to bind selective targets with increased affinity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979811      PMCID: PMC3604998          DOI: 10.1039/c1np00051a

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  148 in total

1.  Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP.

Authors:  J G Bilmen; S Z Khan; M H Javed; F Michelangeli
Journal:  Eur J Biochem       Date:  2001-12

2.  Happy birthday protein kinase C: past, present and future of a superfamily.

Authors:  Fiorenzo Battaini; Daria Mochly-Rosen
Journal:  Pharmacol Res       Date:  2007-05-18       Impact factor: 7.658

Review 3.  Tubulin and FtsZ form a distinct family of GTPases.

Authors:  E Nogales; K H Downing; L A Amos; J Löwe
Journal:  Nat Struct Biol       Date:  1998-06

Review 4.  Structure and function of xanthine oxidoreductase: where are we now?

Authors:  Roger Harrison
Journal:  Free Radic Biol Med       Date:  2002-09-15       Impact factor: 7.376

5.  Olanzapine inhibits glycogen synthase kinase-3beta: an investigation by docking simulation and experimental validation.

Authors:  Mohammad K Mohammad; Ihab M Al-Masri; Mutasem O Taha; Mohamed A S Al-Ghussein; Hatim S Alkhatib; Samer Najjar; Yasser Bustanji
Journal:  Eur J Pharmacol       Date:  2008-01-30       Impact factor: 4.432

6.  Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A.

Authors:  E I Howard; R Sanishvili; R E Cachau; A Mitschler; B Chevrier; P Barth; V Lamour; M Van Zandt; E Sibley; C Bon; D Moras; T R Schneider; A Joachimiak; A Podjarny
Journal:  Proteins       Date:  2004-06-01

7.  Demethoxycurcumin induces Bcl-2 mediated G2/M arrest and apoptosis in human glioma U87 cells.

Authors:  Pratibha Mehta Luthra; Rakesh Kumar; Amresh Prakash
Journal:  Biochem Biophys Res Commun       Date:  2009-05-05       Impact factor: 3.575

Review 8.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

9.  Curcumin is a potent DNA hypomethylation agent.

Authors:  Zhongfa Liu; Zhiliang Xie; William Jones; Ryan E Pavlovicz; Shujun Liu; Jianhua Yu; Pui-kai Li; Jiayuh Lin; Jame R Fuchs; Guido Marcucci; Chenglong Li; Kenneth K Chan
Journal:  Bioorg Med Chem Lett       Date:  2008-12-14       Impact factor: 2.823

10.  Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase.

Authors:  S Reddy; B B Aggarwal
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

View more
  138 in total

1.  Facile synthesis of deuterated and [(14) C]labeled analogs of vanillin and curcumin for use as mechanistic and analytical tools.

Authors:  Odaine N Gordon; Leigh A Graham; Claus Schneider
Journal:  J Labelled Comp Radiopharm       Date:  2013-07-23       Impact factor: 1.921

Review 2.  Carbonyl stress in aging process: role of vitamins and phytochemicals as redox regulators.

Authors:  Volkan Ergin; Reza Ebrahimi Hariry; Cimen Karasu
Journal:  Aging Dis       Date:  2013-10-01       Impact factor: 6.745

3.  Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and/or insulin.

Authors:  Heloisa Einloft Palma; Patrícia Wolkmer; Miguel Gallio; Marcos M B Corrêa; Roberta Schmatz; Gustavo R Thomé; Luciane B Pereira; Verônica S P Castro; Andréia B Pereira; Andressa Bueno; Lizielle S de Oliveira; Debora Rosolen; Thaís R Mann; Bianca S de Cecco; Dominguita L Graça; Sonia T A Lopes; Cinthia M A Mazzanti
Journal:  Mol Cell Biochem       Date:  2013-10-16       Impact factor: 3.396

Review 4.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

5.  Curcumin regulates hepatoma cell proliferation and apoptosis through the Notch signaling pathway.

Authors:  Zheng-Cai Liu; Zhao-Xu Yang; Jing-Shi Zhou; Hong-Tao Zhang; Qi-Ke Huang; Li-Li Dang; Guang-Xin Liu; Kai-Shan Tao
Journal:  Int J Clin Exp Med       Date:  2014-03-15

6.  Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas.

Authors:  Natasha M Crosby; Mistuni Ghosh; Betty Su; Jennifer A Beckstead; Ayako Kamei; Jens B Simonsen; Bing Luo; Leo I Gordon; Trudy M Forte; Robert O Ryan
Journal:  Biochem Cell Biol       Date:  2015-04-20       Impact factor: 3.626

Review 7.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

8.  Curcumin Inhibits Protein Kinase Cα Activity by Binding to Its C1 Domain.

Authors:  Satyabrata Pany; Youngki You; Joydip Das
Journal:  Biochemistry       Date:  2016-11-02       Impact factor: 3.162

Review 9.  Carbon-based Nanomaterials and Curcumin: A Review of Biosensing Applications.

Authors:  Mohammad Mohajeri; Behzad Behnam; Aida Tasbandi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.